Boardroom Alpha
Boardroom Alpha
CBRE · Current Report (Form 8-K) · Filed May 22, 2026

Cbre Group Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 22, 2026
Period
May 21, 2026
Ticker
CBRE
Accession
0001193125-26-237130
Boardroom Alpha · Filing insights

All 10 directors elected; stockholder special meetings proposal rejected; KPMG appointed; say-on-pay approved.

About Cbre Group Inc
Market cap
$37.4B
1Y TSR
+2.1%
3Y TSR
+20.3%
Board grade
B
Sector
Real Estate
CEO
Robert E Sulentic
Last annual meeting: May 21, 2026 · View full Cbre Group Inc profile →
8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 21, 2026

CBRE GROUP, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware

001-32205

94-3391143

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

 

 

2121 North Pearl Street

Suite 300

Dallas, Texas

75201

(Address of Principal Executive Offices)

(Zip Code)

(214) 979-6100

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Class A Common Stock, $0.01 par value per share

 

CBRE

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

This Current Report on Form 8-K is filed by CBRE Group, Inc., a Delaware corporation (the “Company”), in connection with the matters described herein.

Item 5.07 Submission of Matters to a Vote of Security Holders.

(a) The Company held its annual meeting of stockholders (the “Annual Meeting”) on May 21, 2026.

(b) The voting results from the Annual Meeting were as follows:

1.
Each of the following 10 directors was elected to our Board of Directors, to serve until the next annual meeting of stockholders in 2027 or until their respective successors are elected and qualified. Each director received the number of votes set forth below. For each director, there were 9,456,979 broker non-votes.

Name

For

Against

Abstain

Brandon B. Boze

244,536,152

8,506,500

282,148

Vincent Clancy

251,791,855

1,251,764

281,181

Beth F. Cobert

251,747,921

1,160,247

416,632

Reginald H. Gilyard

242,969,905

10,077,931

276,964

Shira D. Goodman

252,290,865

760,175

273,760

Gerardo I. Lopez

247,117,700

5,787,940

419,160

Guy A. Metcalfe

252,120,082

930,639

274,079

Gunjan Soni

252,946,389

75,639

302,772

Robert E. Sulentic

236,814,806

13,888,933

2,621,061

Sanjiv Yajnik

242,965,654

9,768,331

590,815

 

2.
The ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2026 was approved by a vote of 255,196,778 shares in favor, 7,357,550 shares against, and 227,451 shares abstaining. There were no broker non-votes on this proposal.
3.
The advisory approval of named executive officer compensation for the fiscal year ended December 31, 2025 was approved by a vote of 230,735,191 shares in favor, 21,828,542 shares against, and 761,067 shares abstaining. There were 9,456,979 broker non-votes on this proposal.
4.
The stockholder proposal regarding stockholders’ ability to call special stockholder meetings was rejected by a vote of 85,999,804 shares in favor, 166,814,496 shares against, and 510,500 shares abstaining. There were 9,456,979 broker non-votes on this proposal.

 


 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: May 22, 2026

CBRE GROUP, INC.

 

 

 

 

 

 

By:

/s/ EMMA E. GIAMARTINO

 

 

 

Emma E. Giamartino

 

 

 

Chief Financial Officer and Chief Investment Officer

 

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Cbre Group Inc (CBRE)

Reference

Frequently asked questions

When did Cbre Group Inc file this 8-K?
Cbre Group Inc (CBRE) filed this Current Report (Form 8-K) with the SEC on May 22, 2026. The accession number assigned by EDGAR is 0001193125-26-237130.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
All 10 directors elected; stockholder special meetings proposal rejected; KPMG appointed; say-on-pay approved. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Cbre Group Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Cbre Group Inc has filed under CIK 1138118, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer